About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Advances and Unmet Needs in Testicular Cancer: De-Escalating and Diversifying Treatment Options
By
Kenrick Ng
2 Videos
FEATURING
Jonathan Shamash
,
Daniel Richardson
232 views
February 28, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
21:17
Janssen Oncology
The Man Cave
Feat.
J. Hamilton,
M. Fabrizio,
M. Taha
Featured Video
21:09
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Related Content
AUTOPLAY
ON
02:31
Dana-Farber Cancer Institute
Testicular Cancer Highlights From ASCO® GU 2024
Feat.
A. Tewari
03:49
UNC Lineberger Comprehensive Cancer Center
UNC Testicular Cancer Management Updates
Feat.
H. Tan
14:20
Insights from 2023 European Multidisciplinary Congress on Urological Cancers
Management of Clinical Stage IIA/B Seminomatous Germ Cell Tumors
Feat.
C. Oing
16:14
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/R…
Feat.
E. Waller
15:30
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Germ Cell Tumor Stem Cell Transplantation
Feat.
B. Aksoy
18:13
OncoAlert
Treating Genitourinary Cancers With Limited Resources
Feat.
Y. Ürün
04:50
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute Testicular Cancer Updates From ASCO GU …
Feat.
A. Tewari
02:23
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "Association of DAZL Expression With Ri…
Feat.
A. Tewari
13:01
ASCO GU 2023 Conference Coverage
ASCO GU 2023 Interim Analysis of the Prospective Phase II COTRIMS Tr…
Feat.
A. Heidenreich
02:29
Scripps MD Anderson Cancer Center
Testicular Cancer: Primary RPLND for Stage II Seminoma
Feat.
T. Barauskas Dorff
05:58
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Test…
Feat.
A. Meuleman
07:47
PrecisCa
GU Tumor Board: 60 y/o Male Presented With Groin Mass and Diagnosed …
Feat.
B. Rini,
C. Lynn Siegel,
C. Shah,
J. Abel,
A. Drakaki
16:47
Oncology Data Advisor
Personalizing the Approach to Testicular Cancer Management
Feat.
A. Bagrodia
07:28
Oncology Data Advisor
Exploring Recent Advances in Testicular Cancer Surgery and Access to…
Feat.
A. Winer
13:36
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Hematopoietic Stem Cell Transplantation in Germ Cell Tumors
Feat.
A. Mamonova
18:54
Xth Eurasian Hematology-Oncology Congress
Stage I Testicular Cancer: Who Needs Treatment and Which One?
Feat.
O. Dizdar
44:49
40th Anniversary Cisplatin Celebration and Cancer Research Symposium
Platinum and Testicular Cancer: An Oncological Success Story
Feat.
L. Einhorn
02:31
Dana-Farber Cancer Institute
Testicular Cancer Highlights From ASCO® GU 2024
Feat.
A. Tewari
12:16
ecancer
ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…
Feat.
L. Raez
03:49
UNC Lineberger Comprehensive Cancer Center
UNC Testicular Cancer Management Updates
Feat.
H. Tan
